Phase III: NSCLC
Phase 1b: NSCLC
Phase 1a: Solid tumors
Phase II: HER2+ mBC and mGEAC (Part 2)
Phase I: HER2+ mBC and mGEAC (Part 1)
Phase II: Pan-tumor
FOCUS AREA
NON-SMALL CELL LUNG CANCER
DEVELOPMENT STAGE
PHASE I
TARGET
4
Title
Order
2
Subtitle pipeline
Cancer cell-directed
SEO Description
HER2 exon 20 inhibitor (BI 1810631)
Title Tag Value
Content - Card - Zongertinib - Read more